Liz T. Bui
Liz Bui, J.D., Ph.D. is a Vice President & Intellectual Property Counsel at ViaCyte, Inc. a leader in the emerging field of regenerative medicine headquartered in San Diego, California. ViaCyte's clinical candidate products are based on the differentiation of stem cells into pancreatic beta-cell precursors, with the goal to free patients with type 1 and type 2 diabetes from long-term insulin dependence. Dr. Bui oversees all matters related to intellectual property and is instrumental in the execution of corporate partnerships, licensing contracts, and other key business alliances.